Medicare Enrolled
Dr. Barry McCasland, M.D.
Optician · Atlanta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McCasland from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCasland?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McCasland
Dr. Barry McCasland is an optician specialist in Atlanta, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. McCasland performed 656 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McCasland received a total of $28,680 from 73 pharmaceutical and/or device companies across 1132 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McCasland is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ 656 Medicare services
$28,680 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗656
Medicare services
Bottom 47% in GA for optician
Not available
Unique patients (not deduplicated)
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
212 | $93 | $267 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
183 | $64 | $195 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
107 | $118 | $342 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
81 | $74 | $260 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
31 | $100 | $325 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $78 | $275 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
17 | $85 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$28,680
Total received (2018-2024)
Avg $4,097/year across 7 years
Top 5% in GA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
1,132
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,760
2023
$9,491
2022
$3,675
2021
$3,772
2020
$2,202
2019
$2,823
2018
$2,957
Payments by company (2024)
PFIZER INC.
$511
ABBVIE INC.
$505
MDD US Operations, LLC
$370
Novartis Pharmaceuticals Corporation
$195
Kyowa Kirin, Inc.
$180
UCB, Inc.
$172
Lundbeck LLC
$171
Biogen, Inc.
$165
Neurocrine Biosciences, Inc.
$161
Supernus Pharmaceuticals, Inc.
$160
E.R. Squibb & Sons, L.L.C.
$142
Lilly USA, LLC
$122
Celgene Corporation
$114
ARGENX US, INC.
$106
SK Life Science, Inc.
$79
Sumitomo Pharma America, Inc.
$76
Eisai Inc.
$61
SCILEX PHARMACEUTICALS INC.
$59
Grifols USA, LLC
$57
ANI Pharmaceuticals, Inc.
$53
Amneal Pharmaceuticals LLC
$47
EMD Serono, Inc.
$47
Amgen Inc.
$37
Genentech USA, Inc.
$36
CSL Behring
$27
ACADIA Pharmaceuticals Inc
$24
Takeda Pharmaceuticals U.S.A., Inc.
$24
Teva Pharmaceuticals USA, Inc.
$23
HARMONY BIOSCIENCES LLC
$18
TG Therapeutics, Inc.
$18
Top 3 companies account for 36.9% of 2024 payments
All-time payments by company (2018-2024) ›
NOVARTIS PHARMACEUTICALS CORPORATION
$5,389
Teva Pharmaceuticals USA, Inc.
$1,935
Biogen, Inc.
$1,546
ABBVIE INC.
$1,151
UCB, Inc.
$1,126
EMD Serono, Inc.
$1,121
PFIZER INC.
$1,007
Sunovion Pharmaceuticals Inc.
$1,002
MDD US Operations, LLC
$992
Novartis Pharmaceuticals Corporation
$815
Neurocrine Biosciences, Inc.
$656
Kyowa Kirin, Inc.
$580
Amgen Inc.
$565
Lundbeck LLC
$562
Supernus Pharmaceuticals, Inc.
$512
Avanir Pharmaceuticals, Inc.
$505
Lilly USA, LLC
$490
SK Life Science, Inc.
$475
US WorldMeds, LLC
$474
Celgene Corporation
$463
Genentech USA, Inc.
$425
UPSHER-SMITH LABORATORIES LLC
$422
Horizon Therapeutics plc
$409
Grifols USA, LLC
$397
AbbVie Inc.
$363
Adamas Pharmaceuticals, Inc.
$331
Sumitomo Pharma America, Inc.
$323
IMPEL PHARMACEUTICALS INC.
$322
Amneal Pharmaceuticals LLC
$315
Biohaven Pharmaceuticals, Inc.
$308
ACADIA Pharmaceuticals Inc
$288
Biohaven Pharmaceutical Holding Company Ltd.
$279
GENZYME CORPORATION
$247
Acorda Therapeutics, Inc
$209
Upsher-Smith Laboratories LLC
$208
Alexion Pharmaceuticals, Inc.
$204
E.R. Squibb & Sons, L.L.C.
$199
Abbott Laboratories
$198
ARGENX US, INC.
$167
Neurelis, Inc.
$148
Allergan, Inc.
$140
Janssen Pharmaceuticals, Inc
$130
Avion Pharmaceuticals
$105
MITSUBISHI TANABE PHARMA AMERICA, INC.
$90
Impax Laboratories, Inc.
$80
CSL Behring
$79
Alnylam Pharmaceuticals Inc.
$72
SANOFI-AVENTIS U.S. LLC
$63
Allergan Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$62
AbbVie, Inc.
$61
Eisai Inc.
$61
Mallinckrodt LLC
$60
SCILEX PHARMACEUTICALS INC.
$59
ANI Pharmaceuticals, Inc.
$53
HARMONY BIOSCIENCES LLC
$40
Aprecia Pharmaceuticals, LLC
$36
LivaNova USA, Inc.
$33
Mitsubishi Tanabe Pharma America, Inc.
$31
Collegium Pharmaceutical, Inc.
$29
Egalet US Inc
$19
Axsome Therapeutics, Inc.
$18
TG Therapeutics, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Currax Pharmaceuticals LLC
$18
Mallinckrodt Enterprises LLC
$18
Banner Life Sciences, LLC
$16
LINUS HEALTH, INC.
$16
Merck Sharp & Dohme Corporation
$16
Harmony Biosciences LLC
$13
ARBOR PHARMACEUTICALS, INC.
$13
Assertio Therapeutics, Inc.
$12
Merck Sharp & Dohme LLC
$12
Top 3 companies account for 30.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPLATZER Vascular Plugs · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · CORE COGNITIVE EVALUATION · DUOPA · Dhivy · Duopa · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · Enspryng · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · Merlin Connectivity and Remote · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qelbree · RADICAVA · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRIX · Soliris · Spritam · Sunosi · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · Xadago · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · Zilbrysq · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
611
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McCasland is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McCasland experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McCasland performed 212 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McCasland receive payments from pharmaceutical companies?
Yes. Dr. McCasland received a total of $28,680 from 73 companies across 1,132 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCasland's costs compare to other opticians in Atlanta?
Dr. McCasland's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCasland) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Atlanta
Browse opticians in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Opticians in GA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in GA
Which GA opticians receive the most from drug and device companies.
By company
NOVARTIS PHARMACEUTICALS CORPORATION Payments to Doctors
See all physicians who received payments from NOVARTIS PHARMACEUTICALS CORPORATION.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology